REDUXIN (Sibutramine, Reductil, Meridia, Siredia, Sibutrex) - is a medication that is used to treat obesity. It works by increasing natural chemicals in the brain thus helping enhance satiety. Reduxin also suppresses appetite and feeling of hunger. By stimulating metabolism Reduxin increases the energy consumption, and induces the fat tissues to be used as the main source of energy. Reduxin gradually decreases body weight - 0,5 kg per week. Please consult your doctor and note the side effects before buying this product: https://en.wikipedia.org/wiki/Sibutramine
- Treat Obesity
- Reduce Fat Mass
- Suppress Appetite and Provide Saturation
GUARANTEE & EXPIRY DATE
100% Original from the Russian Promomed.
All packs are air tight sealed and expire up to 07.2022.
Further read: https://en.wikipedia.org/wiki/Sibutramine
Reduxin contains the active substance - sibutramine. It inhibits the reuptake of serotonin and norepinephrine from the synaptic cleft, potentiates synergistic interactions of central noradrenaline and serotonergic systems. Reduces the appetite and the amount of consumed food (provides the feeling of saturation), increases thermogenesis (due to the mediated activation of beta3-adrenoreceptors), affects brown fatty tissue. Stimulates the formation of active metabolites (primary and secondary amines), which are more potent in inhibiting of neurotransmitters reuptake than sibutramine. Sibutramine affects the brown adipose tissue, decreases amounts of triglycerides, total cholesterol, LDL cholesterol, and uric acid.
PACKAGING & DOSAGE
Reduxin comes in the form of capsules. Each capsule contains sibutramine hydrochloride monohydrate - 10 or 15mg, microcrystalline cellulose 153.5mg
For oral administration. The capsule should be taken 1 time in the morning on an empty stomach or with meals.
Treatment should not last more than 3 months in patients who do not respond well enough to therapy, i.e. those who during the 3 months of treatment cannot achieve 5% weight loss of the initial starting weight. Treatment should not be continued if, in further therapy, after the body weight reduction is achieved, the patient again adds 3 kg or more in the body mass. The duration of treatment should not exceed 2 years, since there is no data on efficacy and safety for a longer period of sibutramine intake. Treatment Reduxin should be carried out in conjunction with diet and exercise under the supervision of a doctor who has a practical experience in the treatment of obesity.
Note: The MHRA and FDA has not evaluated or endorsed this product. Please consult your physician prior to using this or any other nutritional supplements or medications. Please consult your doctor and note the side effects before buying this product: https://en.wikipedia.org/wiki/Sibutramine
Store in dry place at room temperature. Do not exceed storage temperature higher than 25 degrees Celcius. Keep away from direct sunlight. Keep locked and away from children.
Ask us any questions about Reduxin.